The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending to grant a marketing authorisation for the medicinal product Extavia, which is Betaseron (called Betaferon in Europe) sold via Novartis via an agreement with Bayer.
Not earth-shattering news, but useful to know what name they use so you understand it when you hear it.
